Page 4 - Patrickr Oneil News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrickr oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrickr Oneil Today - Breaking & Trending Today

Ionis Pharmaceuticals (NASDAQ:IONS) Shares Gap Down to $43.33

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) shares gapped down prior to trading on Wednesday . The stock had previously closed at $43.33, but opened at $40.49. Ionis Pharmaceuticals shares last traded at $41.18, with a volume of 334,112 shares changing hands. Wall Street Analyst Weigh In A number of research firms have recently commented […] ....

Sanfordc Bernstein , Patrickr Oneil , Securities Exchange Commission , Vanguard Group Inc , Norges Bank , Ionis Pharmaceuticals , Tweedy Browne Co , Institutional Trading Of Ionis Pharmaceuticals , Ionis Pharmaceuticals Company Profile , Ionis Pharmaceuticals Stock Performance , Morgan Stanley , Ionis Pharmaceuticals Inc , News Ratings For Ionis Pharmaceuticals Daily , Get Rating , Exchange Commission , Asset Management , Vanguard Group , Ionis Core , Ionis Pharmaceuticals Daily , Nasdaq Ions ,

Nikko Asset Management Americas Inc. Has $12.71 Million Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Nikko Asset Management Americas Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 336,732 shares of the company’s stock after selling 100,444 shares during the quarter. Nikko […] ....

Patrickr Oneil , Banque Cantonale Vaudoise , Ionis Pharmaceuticals Company Profile , Nikko Asset Management Americas Inc , Almanack Investment Partners , Guardian Wealth Advisors , Ionis Pharmaceuticals , Exchange Commission , Ionis Pharmaceuticals Stock , Ionis Pharmaceuticals Inc , Quarter For Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Royal Bank , Nikko Asset Management Americas , Get Rating , Asset Management Americas , Wealth Advisors , Investment Partners , Cantonale Vaudoise , Ionis Core , Visit Holdingschannel , Ionis Pharmaceuticals Daily , Nasdaq Ions , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Nikko Asset Management Americas Inc. Trims Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Nikko Asset Management Americas Inc. lessened its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 336,732 shares of the company’s stock after selling 100,444 shares during […] ....

Dekabank Deutsche Girozentrale , Sanfordc Bernstein , Patrickr Oneil , Vanguard Personalized Indexing Management , Exchange Commission , Ionis Pharmaceuticals Company Profile , Ionis Pharmaceuticals , Ionis Pharmaceuticals Stock Performance , Nikko Asset Management Americas Inc , Tower Research Capital , Gateway Investment Advisers , Ionis Pharmaceuticals Inc , Morgan Stanley , Quarter For Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Nikko Asset Management Americas , Get Rating , Asset Management Americas , Research Capital , Investment Advisers , Personalized Indexing Management , Bank Deutsche Girozentrale , Ionis Core , Visit Holdingschannel , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $46.64 Average Price Target from Brokerages

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has been given a consensus recommendation of “Hold” by the fourteen ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. […] ....

United States , Patrickr Oneil , News Ratings For Ionis Pharmaceuticals Daily , Securities Exchange Commission , Raymond James Financial Services Advisors Inc , Institutional Trading Of Ionis Pharmaceuticals , Ionis Pharmaceuticals , Metlife Investment Management , Analyst Recommendations For Ionis Pharmaceuticals , Royal Bank , Morgan Stanley , Ionis Pharmaceuticals Inc , Us Bancorp , Ionis Pharmaceuticals Price Performance , American Century Companies Inc , Financial Services Group Inc , Get Rating , Marketbeat Ratings , Exchange Commission , James Financial Services Advisors , Century Companies , Services Group , Ionis Core , Ionis Pharmaceuticals Daily , Nasdaq Ions ,

126,300 Shares in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Purchased by M28 Capital Management LP

M28 Capital Management LP bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 126,300 shares of the company’s stock, valued at approximately $4,770,000. Ionis Pharmaceuticals makes up 4.5% of M28 Capital Management LP’s holdings, making the stock its 6th largest […] ....

United States , Patrickr Oneil , Delphia United States Inc , News Ratings For Ionis Pharmaceuticals Daily , Needham Company , Profund Advisors , Quarter For Ionis Pharmaceuticals , Ionis Pharmaceuticals Price Performance , Lincoln National Corp , Commerce Bank , Ionis Pharmaceuticals , Ionis Pharmaceuticals Inc , Get Rating , Financial Advisors , National Corp , Ionis Core , Visit Holdingschannel , Ionis Pharmaceuticals Daily , Nasdaq Ions , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,